The Enterprise Value as of December 2024 (TTM) for Theseus Pharmaceuticals, Inc. (THRX) is 138.26M

According to Theseus Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 138.26M. This represents a change of -31.85% compared to the average of 202.88M of the last 4 quarters.

Theseus Pharmaceuticals, Inc. (THRX) Historical Enterprise Value (quarterly & annually)

How has THRX Enterprise Value performed in the past?

The mean historical Enterprise Value of Theseus Pharmaceuticals, Inc. over the last ten years is 165.37M. The current 138.26M Enterprise Value has changed 8.26% with respect to the historical average. Over the past ten years (40 quarters), THRX's Enterprise Value was at its highest in in the September 2021 quarter at 575.95M. The Enterprise Value was at its lowest in in the September 2020 quarter at 0.

Theseus Pharmaceuticals, Inc. (THRX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Theseus Pharmaceuticals, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Theseus Pharmaceuticals, Inc. (THRX) Average Enterprise Value

How has THRX Enterprise Value performed in the past?

The current Enterprise Value of Theseus Pharmaceuticals, Inc. (THRX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Theseus Pharmaceuticals, Inc. (THRX) Enterprise Value vs. Peers

How is THRX’s Enterprise Value compared to its peers?

Theseus Pharmaceuticals, Inc.’s Enterprise Value is less than aTyr Pharma, Inc. (138.44M), less than Relay Therapeutics, Inc. (623.90M), greater than Century Therapeutics, Inc. (88.73M), less than Blueprint Medicines Corporation (6.12B), greater than PMV Pharmaceuticals, Inc. (42.60M), less than Cullinan Oncology, Inc. (591.52M), less than Enliven Therapeutics, Inc. (1.04B), greater than Immuneering Corporation (27.35M), less than Gracell Biotechnologies Inc. (5.66B), less than Monte Rosa Therapeutics, Inc. (356.78M), less than Design Therapeutics, Inc. (323.81M), less than Erasca, Inc. (685.22M), greater than X4 Pharmaceuticals, Inc. (79.21M), greater than Galera Therapeutics, Inc. (-6768842.00), less than Terns Pharmaceuticals, Inc. (234.86M), less than Day One Biopharmaceuticals, Inc. (859.59M), greater than HOOKIPA Pharma Inc. (-37325309.00), less than Mersana Therapeutics, Inc. (141.64M), less than Arcus Biosciences, Inc. (1.32B),

Build a custom stock screener for Theseus Pharmaceuticals, Inc. (THRX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Theseus Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Theseus Pharmaceuticals, Inc. (THRX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Theseus Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.